GAITHERSBURG, Md.--Gene Logic will be the first company to use Affymetrix's GeneChip probe arrays to build large, commercially available gene expression database products, the companies announced last week. The collaboration with Affymetrix was first initiated by Oncormed, which was acquired by Gene Logic last year.

Stephen Push, Gene Logic's vice-president for corporate communications, told BioInform that the gene expression databases created with GeneChip probe arrays will be sold on a nonexclusive basis to pharmaceutical and biotechnology companies.